Header cover image

U.S. Pharma Industry Analysis

UpdatedApr 29, 2024
DataAggregated Company Financials
Companies284
  • 7D-0.01%
  • 3M1.9%
  • 1Y9.5%
  • YTDn/a

Last week, the Pharma industry hasn't moved much but Merck is up 4.3% in that time. As for the the longer term, the industry is up 11% over the past 12 months. As for the next few years, earnings are expected to grow by 23% per annum.

Industry Valuation and Performance

Has the U.S. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 29 Apr 2024US$1.8tUS$359.5bUS$17.5b22.4x102.8x5x
Wed, 27 Mar 2024US$1.9tUS$355.3bUS$22.6b18.8x82.8x5.3x
Fri, 23 Feb 2024US$1.9tUS$355.0bUS$23.9b29x78.6x5.3x
Sun, 21 Jan 2024US$1.7tUS$375.2bUS$33.9b27.7x51.6x4.7x
Tue, 19 Dec 2023US$1.6tUS$375.1bUS$33.9b26.7x48.6x4.4x
Thu, 16 Nov 2023US$1.6tUS$375.5bUS$34.2b31.1x48x4.4x
Sat, 14 Oct 2023US$1.7tUS$381.8bUS$43.8b18.3x38.9x4.5x
Mon, 11 Sep 2023US$1.8tUS$381.8bUS$43.9b19.1x41.6x4.8x
Wed, 09 Aug 2023US$1.8tUS$381.3bUS$44.2b20.5x40.2x4.7x
Fri, 07 Jul 2023US$1.7tUS$392.8bUS$60.2b19.3x28.1x4.3x
Sun, 04 Jun 2023US$1.7tUS$393.0bUS$60.5b18.9x28.3x4.4x
Tue, 02 May 2023US$1.7tUS$400.2bUS$62.2b17.7x27.3x4.2x
Thu, 30 Mar 2023US$1.6tUS$401.1bUS$69.6b14.5x22.4x3.9x
Sat, 25 Feb 2023US$1.6tUS$401.8bUS$68.5b17.4x23.1x3.9x
Mon, 23 Jan 2023US$1.7tUS$403.7bUS$70.6b17.7x24x4.2x
Wed, 21 Dec 2022US$1.7tUS$403.7bUS$70.7b16.5x24.5x4.3x
Fri, 18 Nov 2022US$1.7tUS$403.7bUS$70.6b13.9x24.2x4.2x
Sun, 16 Oct 2022US$1.6tUS$403.0bUS$71.3b12.5x22.1x3.9x
Tue, 13 Sep 2022US$1.6tUS$403.0bUS$71.3b13.7x22.6x4x
Thu, 11 Aug 2022US$1.7tUS$402.8bUS$70.2b17.2x23.6x4.1x
Sat, 09 Jul 2022US$1.7tUS$392.4bUS$65.1b21.9x26.2x4.3x
Mon, 06 Jun 2022US$1.7tUS$392.5bUS$64.7b21.7x25.7x4.2x
Wed, 04 May 2022US$1.6tUS$381.1bUS$60.0b20.8x27.2x4.3x
Fri, 01 Apr 2022US$1.7tUS$373.9bUS$60.3b21.1x27.5x4.4x
Sun, 27 Feb 2022US$1.5tUS$373.4bUS$59.4b21.3x25.9x4.1x
Tue, 25 Jan 2022US$1.6tUS$361.3bUS$37.7b22.8x41.4x4.3x
Thu, 23 Dec 2021US$1.7tUS$361.1bUS$38.1b22.8x43.3x4.6x
Sat, 20 Nov 2021US$1.6tUS$360.7bUS$38.2b23.9x41.8x4.4x
Mon, 18 Oct 2021US$1.5tUS$337.7bUS$24.8b21.6x60.3x4.4x
Wed, 15 Sep 2021US$1.5tUS$338.7bUS$25.4b18.8x59.2x4.4x
Fri, 13 Aug 2021US$1.6tUS$338.5bUS$25.8b22.1x62.1x4.7x
Tue, 08 Jun 2021US$1.5tUS$323.4bUS$21.4b20.5x68.9x4.6x
Price to Earnings Ratio

71.9x


Total Market Cap: US$1.4tTotal Earnings: US$19.6bTotal Revenue: US$315.6bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Pharma Industry Price to Earnings3Y Average 41.2x202220232024
Current Industry PE
  • Investors are optimistic on the American Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 103x which is higher than its 3-year average PE of 41.2x.
  • The 3-year average PS ratio of 4.4x is lower than the industry's current PS ratio of 5.0x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 3.7% per year over the last three years.
  • Meanwhile revenues for these companies have grown 4.4% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does U.S. Pharma compare with similar industries?

US Market1.96%
Healthcare0.45%
Pharma-0.013%
Pharma-0.013%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
MRK MerckUS$131.203.4%
+US$10.8b		12.8%PE144.1x
ZTS ZoetisUS$158.428.8%
+US$5.9b		-11.8%PE30.9x
LLY Eli LillyUS$733.510.3%
+US$2.0b		80.8%PE126.1x
TEVA Teva Pharmaceutical IndustriesUS$13.817.2%
+US$1.1b		56.2%PS1x
VTRS ViatrisUS$11.572.8%
+US$380.0m		23.6%PE251.2x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

RPRX

US$28.00

Royalty Pharma

7D

0.6%

1Y

-20.7%

Royalty Pharma (NASDAQ:RPRX) Will Pay A Dividend Of $0.21

Apr 28
Royalty Pharma (NASDAQ:RPRX) Will Pay A Dividend Of $0.21

NMRA

US$9.15

Neumora Therapeutics

7D

-12.1%

1Y

n/a

PFE

US$25.40

Pfizer

7D

-3.3%

1Y

-35.2%

OGN

US$18.55

Organon

7D

3.1%

1Y

-24.3%

BMY

US$44.85

Bristol-Myers Squibb

7D

-8.7%

1Y

-34.4%

ARVN

US$32.37

Arvinas

7D

-7.2%

1Y

19.7%

MRK

US$131.20

Merck

7D

3.4%

1Y

12.8%

PRGO

US$31.94

Perrigo

7D

6.3%

1Y

-14.9%

VTRS

US$11.57

Viatris

7D

2.8%

1Y

23.6%

Inflation Reduction Act: A Bullish Catalyst For Viatris Inc.

Apr 24

ITCI

US$73.26

Intra-Cellular Therapies

7D

-1.7%

1Y

16.0%

LLY

US$733.51

Eli Lilly

7D

0.3%

1Y

80.8%

What You Can Learn From Eli Lilly and Company's (NYSE:LLY) P/S

Apr 22
What You Can Learn From Eli Lilly and Company's (NYSE:LLY) P/S

JNJ

US$146.14

Johnson & Johnson

7D

-2.0%

1Y

-10.7%

Johnson & Johnson (NYSE:JNJ) Will Pay A Larger Dividend Than Last Year At $1.24

Apr 19
Johnson & Johnson (NYSE:JNJ) Will Pay A Larger Dividend Than Last Year At $1.24

OCUL

US$4.75

Ocular Therapeutix

7D

-6.5%

1Y

-23.2%

TEVA

US$13.81

Teva Pharmaceutical Industries

7D

7.2%

1Y

56.2%

ZTS

US$158.42

Zoetis

7D

8.8%

1Y

-11.8%

GHRS

US$10.51

GH Research

7D

-10.3%

1Y

16.8%